KR20240110653A - 조혈 줄기 세포의 유지 및 확장을 위한 방법 및 조성물 - Google Patents

조혈 줄기 세포의 유지 및 확장을 위한 방법 및 조성물 Download PDF

Info

Publication number
KR20240110653A
KR20240110653A KR1020247021309A KR20247021309A KR20240110653A KR 20240110653 A KR20240110653 A KR 20240110653A KR 1020247021309 A KR1020247021309 A KR 1020247021309A KR 20247021309 A KR20247021309 A KR 20247021309A KR 20240110653 A KR20240110653 A KR 20240110653A
Authority
KR
South Korea
Prior art keywords
agonist
culture medium
concentration
hscs
hsc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247021309A
Other languages
English (en)
Korean (ko)
Inventor
엔젤리카 엠. 고메스 우엘트쉬
Original Assignee
트레일헤드 바이오시스템즈 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 트레일헤드 바이오시스템즈 인크. filed Critical 트레일헤드 바이오시스템즈 인크.
Publication of KR20240110653A publication Critical patent/KR20240110653A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020247021309A 2021-11-30 2022-11-29 조혈 줄기 세포의 유지 및 확장을 위한 방법 및 조성물 Pending KR20240110653A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163284360P 2021-11-30 2021-11-30
US63/284,360 2021-11-30
PCT/US2022/051195 WO2023101943A1 (en) 2021-11-30 2022-11-29 Methods and compositions for maintaining and expanding hematopoietic stem cells

Publications (1)

Publication Number Publication Date
KR20240110653A true KR20240110653A (ko) 2024-07-15

Family

ID=84901401

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247021309A Pending KR20240110653A (ko) 2021-11-30 2022-11-29 조혈 줄기 세포의 유지 및 확장을 위한 방법 및 조성물

Country Status (9)

Country Link
US (1) US20230167408A1 (https=)
EP (1) EP4441205A1 (https=)
JP (1) JP2024541616A (https=)
KR (1) KR20240110653A (https=)
CN (1) CN118302519A (https=)
AU (1) AU2022399413A1 (https=)
CA (1) CA3238518A1 (https=)
IL (1) IL312661A (https=)
WO (1) WO2023101943A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080674A1 (en) 2023-10-09 2025-04-17 Trailhead Biosystems Inc. Methods to improve enduring hematopoietic stem cell transplantation
WO2025129033A1 (en) * 2023-12-14 2025-06-19 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for hematopoietic stem and progenitor cell expansion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2488425A1 (en) * 2002-06-07 2003-12-18 Es Cell International Pte Ltd Methods of regulating differentiation in stem cells
CA2948871A1 (en) * 2014-05-22 2015-11-26 Fred Hutchinson Cancer Research Center Lilrb2 and notch-mediated expansion of hematopoietic precursor cells
US10669528B2 (en) * 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
EP4049665B1 (en) * 2016-03-15 2025-03-12 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
US20180163177A1 (en) * 2016-12-11 2018-06-14 Healthbanks Biotech Co. Ltd. Serum-free culture medium and method for expanding hematopoietic stem cells
GB201706544D0 (en) * 2017-04-25 2017-06-07 Plasticell Ltd Method
CN114286860A (zh) * 2019-08-29 2022-04-05 味之素株式会社 由含有间充质干细胞的生物来源细胞试样制造间充质干细胞的方法

Also Published As

Publication number Publication date
IL312661A (en) 2024-07-01
CN118302519A (zh) 2024-07-05
JP2024541616A (ja) 2024-11-08
WO2023101943A1 (en) 2023-06-08
AU2022399413A1 (en) 2024-05-23
EP4441205A1 (en) 2024-10-09
US20230167408A1 (en) 2023-06-01
CA3238518A1 (en) 2023-06-08

Similar Documents

Publication Publication Date Title
Manesia et al. Highly proliferative primitive fetal liver hematopoietic stem cells are fueled by oxidative metabolic pathways
JP2020124212A (ja) ヒト造血幹／前駆細胞のエクスビボ拡大のための組成物および方法
CN110268048B (zh) 从人多能干细胞生成心房心肌细胞和心室心肌细胞谱系
US20130136722A1 (en) Methods of Ex Vivo Expansion of Blood Progenitor Cells, and Generation of Composite Grafts
US20230167408A1 (en) Methods and compositions for maintaining and expanding hematopoietic stem cells
Gao et al. Tetrahydroxy stilbene glucoside rejuvenates aging hematopoietic stem cells with predilection for lymphoid differentiation via AMPK and Tet2
JP2023504424A (ja) 代謝は内皮から造血への移行中の決定的系統指定を誘導する
US20230174938A1 (en) Methods and compositions for generating human erythroid progenitor cells
Migliaccio et al. Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death
Tatetsu et al. Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465)
EP3452581B1 (en) 4hpr and its use in the culturing of hematopoietic stem cells
Uslu et al. Development of a novel and synthetic HematoMiR technology that broadly modulates quiescence of stem cells and enhances HSC expansion
Keyvani Chahi CHARACTERIZING THE ROLE OF THE TRANSCRIPTION FACTOR PLAG1 IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS
Chen Regulation of human hematopoietic stem cell lineage commitment
Poscablo Alterations to Platelet Differentiation Pathways Arising From Hematopoietic Stem Cells During Aging
Huang ZFP36L2 in Development and Adulthood: A Critical Regulator of Hematopoietic Stem Cell Homeostasis
Alsayari Small molecule to enhance the haematopoietic differentiation capability in mouse induced pluripotent stem cells
Nguyen-McCarty Characterizing A Signaling Network That Maintains Hematopoietic Stem Cells
Arede Novel roles of KAT2A chromatin complexes ATAC and SAGA in normal and malignant haematopoiesis
Chen MLL-AF9 Initiates Leukemic Transformation from Fast-Proliferating Myeloid Progenitors
Sousae Methylation of histone H3 lysine-9 regulates hematopoietic stem cell differentiation
WO2025080674A1 (en) Methods to improve enduring hematopoietic stem cell transplantation
Sekulovic Characterization of mouse hematopoietic stem cells primed to actively self-renew by NUP98-HOXA10hd fusion gene
Lee Epigenetics of osteoblast differentiation within an inflammatory environment
Chanda Molecular Mechanisms of Hematopoietic Stem Cell Development: The Role of Retinoic Acid Signaling

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000